BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nedrow JR, White AG, Modi J, Nguyen K, Chang AJ, Anderson CJ. Positron emission tomographic imaging of copper 64- and gallium 68-labeled chelator conjugates of the somatostatin agonist tyr3-octreotate. Mol Imaging 2014;13. [PMID: 25060207 DOI: 10.2310/7290.2014.00020] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Pham W. Principles for the Design of PET Probes. Principles of Molecular Probe Design and Applications 2023. [DOI: 10.1007/978-981-19-5739-0_3] [Reference Citation Analysis]
2 Davey PRWJ, Paterson BM. Modern Developments in Bifunctional Chelator Design for Gallium Radiopharmaceuticals. Molecules 2022;28. [PMID: 36615397 DOI: 10.3390/molecules28010203] [Reference Citation Analysis]
3 Gower-Fry L, Kronemann T, Dorian A, Pu Y, Jaworski C, Wängler C, Bartenstein P, Beyer L, Lindner S, Jurkschat K, Wängler B, Bailey JJ, Schirrmacher R. Recent Advances in the Clinical Translation of Silicon Fluoride Acceptor (SiFA) 18F-Radiopharmaceuticals. Pharmaceuticals (Basel) 2021;14:701. [PMID: 34358127 DOI: 10.3390/ph14070701] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zha Z, Wu Z, Choi SR, Ploessl K, Smith M, Alexoff D, Zhu L, Kung HF. A New [68Ga]Ga-HBED-CC-Bisphosphonate as a Bone Imaging Agent. Mol Pharm 2020;17:1674-84. [PMID: 32251600 DOI: 10.1021/acs.molpharmaceut.0c00103] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
5 Zhang M, Jacobson O, Kiesewetter DO, Ma Y, Wang Z, Lang L, Tang L, Kang F, Deng H, Yang W, Niu G, Wang J, Chen X. Improving the Theranostic Potential of Exendin 4 by Reducing the Renal Radioactivity through Brush Border Membrane Enzyme-Mediated Degradation. Bioconjug Chem 2019;30:1745-53. [PMID: 31181890 DOI: 10.1021/acs.bioconjchem.9b00280] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
6 Kaeppeli SAM, Schibli R, Mindt TL, Behe M. Comparison of desferrioxamine and NODAGA for the gallium-68 labeling of exendin-4. EJNMMI Radiopharm Chem 2019;4:9. [PMID: 31659487 DOI: 10.1186/s41181-019-0060-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
7 Guillou A, Lima LMP, Esteban-Gómez D, Le Poul N, Bartholomä MD, Platas-Iglesias C, Delgado R, Patinec V, Tripier R. Methylthiazolyl Tacn Ligands for Copper Complexation and Their Bifunctional Chelating Agent Derivatives for Bioconjugation and Copper-64 Radiolabeling: An Example with Bombesin. Inorg Chem 2019;58:2669-85. [PMID: 30689368 DOI: 10.1021/acs.inorgchem.8b03280] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
8 Radford LL, Papagiannopoulou D, Gallazzi F, Berendzen A, Watkinson L, Carmack T, Lewis MR, Jurisson SS, Hennkens HM. Synthesis and evaluation of Re/99mTc(I) complexes bearing a somatostatin receptor-targeting antagonist and labeled via a novel [N,S,O] clickable bifunctional chelating agent. Bioorg Med Chem 2019;27:492-501. [PMID: 30594453 DOI: 10.1016/j.bmc.2018.12.028] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
9 Marciniak A, Brasuń J. Somatostatin analogues labeled with copper radioisotopes: current status. J Radioanal Nucl Chem 2017;313:279-89. [PMID: 28804185 DOI: 10.1007/s10967-017-5323-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
10 Spang P, Herrmann C, Roesch F. Bifunctional Gallium-68 Chelators: Past, Present, and Future. Seminars in Nuclear Medicine 2016;46:373-94. [DOI: 10.1053/j.semnuclmed.2016.04.003] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 8.3] [Reference Citation Analysis]
11 Farkas R, Siwowska K, Ametamey SM, Schibli R, van der Meulen NP, Müller C. (64)Cu- and (68)Ga-Based PET Imaging of Folate Receptor-Positive Tumors: Development and Evaluation of an Albumin-Binding NODAGA-Folate. Mol Pharm 2016;13:1979-87. [PMID: 27145400 DOI: 10.1021/acs.molpharmaceut.6b00143] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 5.3] [Reference Citation Analysis]
12 Nedrow JR, Anderson CJ. Emerging Radiometals for PET Imaging. Encyclopedia of Inorganic and Bioinorganic Chemistry 2016. [DOI: 10.1002/9781119951438.eibc2447] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
13 Wu N, Kang CS, Sin I, Ren S, Liu D, Ruthengael VC, Lewis MR, Chong HS. Promising bifunctional chelators for copper 64-PET imaging: practical (64)Cu radiolabeling and high in vitro and in vivo complex stability. J Biol Inorg Chem 2016;21:177-84. [PMID: 26666778 DOI: 10.1007/s00775-015-1318-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
14 Fan D, Zhang X, Zhong L, Liu X, Sun Y, Zhao H, Jia B, Liu Z, Zhu Z, Shi J, Wang F. (68)Ga-labeled 3PRGD2 for dual PET and Cerenkov luminescence imaging of orthotopic human glioblastoma. Bioconjug Chem. 2015;26:1054-1060. [PMID: 25853280 DOI: 10.1021/acs.bioconjchem.5b00169] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
15 Beaino W, Nedrow JR, Anderson CJ. Evaluation of (68)Ga- and (177)Lu-DOTA-PEG4-LLP2A for VLA-4-Targeted PET Imaging and Treatment of Metastatic Melanoma. Mol Pharm 2015;12:1929-38. [PMID: 25919487 DOI: 10.1021/mp5006917] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 4.4] [Reference Citation Analysis]